# Wright Medical Group Wright Medical Group is a Corporate Investor based in Flower Mound, United States. ## Overview - **Organization type:** Corporate Investor - **Headquarters:** Flower Mound, United States - **Region:** North America - **Address:** Flower Mound, TX, United States - **Founded:** 1950 - **Assets under management:** Undisclosed - **Website:** wright.com - **LinkedIn:** https://www.linkedin.com/company/wrightmedical ## Regulatory record - **Reports private funds:** No ## About Wright Medical Group was established in 1950 by Frank O. Wright, growing from a small manufacturing operation into a pure-play orthopedic device company. The firm concentrated on extremities and biologics, specifically designing implants and bone-fixation devices for the foot, ankle, and upper extremities. Former President and CEO Robert J. Palmisano later led a strategic pivot to divest large-joint businesses, sharpening the company's focus on the fast-growing extremities segment. The business was historically headquartered in Arlington, Tennessee, with executive offices in Amsterdam and additional operations in Bloomington, Minnesota. The company's investment posture was that of an operating corporate acquirer, not an institutional allocator. It deployed capital primarily through targeted acquisitions to build its extremities portfolio. Key historic transactions included the $3.3 billion merger with Tornier N.V. in 2015, which combined Wright's U.S. foot-and-ankle strength with Tornier's European upper-extremities and shoulder implant business. This created a specialized orthopedics platform operating across North America and Europe. Prior to its acquisition, Wright Medical maintained a global manufacturing footprint and an intellectual property portfolio covering joint replacement and biologic technologies. Wright Medical operated with thousands of employees across facilities in Memphis, Arlington, and the Netherlands before its acquisition. The company was a member of the Greater Memphis Medical Device Council and MedTech Europe, where it participated in the Ethics and Compliance Committee. In November 2020, Stryker Corporation completed its acquisition of Wright Medical Group N.V., integrating the company's extremities and biologics portfolio into Stryker's broader orthopedic franchise. The deal followed a period of portfolio streamlining by Wright, including the divestiture of its OrthoRecon hip and knee business. The firm's structural differentiator was its singular commitment to the extremities market. While diversified orthopedic giants competed across hips, knees, spine, and trauma, Wright Medical deliberately concentrated its R&D and acquisition capital on the less-crowded foot, ankle, and upper-limb segments. This focus made it an essential supplier to foot-and-ankle specialists and ultimately a strategically valuable acquisition target for Stryker, which needed that specific surgeon-customer relationship to compete in the expanding extremities category. ## Sectors - Medical Devices ## Offices - Amsterdam, Netherlands - Memphis, TN - Bloomington, MN ## People - Frank O. Wright — Founder - Robert J. Palmisano — Former President and CEO ## Questions ### What was Wright Medical Group's investment strategy? Wright Medical was not a financial asset manager but a corporate strategic acquirer. It deployed capital into mergers and acquisitions to expand its orthopedic extremities product portfolio, most notably through its 2015 merger with Tornier N.V. The goal was to consolidate the foot, ankle, and upper-extremities implant market rather than generate returns from third-party capital. ### Why did Stryker acquire Wright Medical Group? Stryker sought to capture the fast-growing extremities segment, where Wright Medical held a leading U.S. foot-and-ankle franchise and a strong upper-extremities business inherited from Tornier. The $4.7 billion deal closed in November 2020 and gave Stryker a specialized surgeon-facing sales channel distinct from its large-joint reconstruction business. ### Does Wright Medical Group still exist as an independent entity? No. Wright Medical Group N.V. was acquired by Stryker Corporation in 2020 and its brand and product lines were integrated into Stryker's Trauma & Extremities division. The former corporate entities were dissolved as part of the merger. Any remaining references to Wright Medical in the market describe legacy products or pre-acquisition history. ### What was Wright Medical's corporate structure before the acquisition? The parent company, Wright Medical Group N.V., was incorporated in the Netherlands with executive offices in Amsterdam, while its U.S. operational hub was in Memphis and Arlington, Tennessee. This structure allowed for a competitive tax position while maintaining a deep manufacturing and distribution presence in the U.S. ### How did the Tornier merger reshape Wright Medical? The 2015 merger created the world's largest pure-play extremities orthopedic company. Tornier, based in the Netherlands, brought European market access and a broad shoulder portfolio. The combined entity launched with a combined equity value of approximately $3.3 billion and immediately became a more serious competitor to the extremities divisions of Zimmer Biomet, DePuy Synthes, and Stryker itself. ## Related profiles - [Wright Family Foundation](https://altss.com/profile/wright-family-foundation) - [Wrise Wealth Management](https://altss.com/profile/wrise-wealth-management) --- Last updated: 2026-06-03T20:00:00.000Z Canonical page: https://altss.com/profile/wright-medical-group Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology